65 results on '"Dotti, G"'
Search Results
2. ATTIL12-T CELL THERAPY FOR SIMULTANEOUSLY DISRUPTING STROMA/TUMORS AND INDUCTION OF ENDOGENOUS TCR-T CELLS
3. The Effect of Number of Gait Cycles on Principal Activation Extraction
4. Anticancer innovative therapy: Highlights from the ninth annual meeting
5. T Cell Therapies
6. Shc Overexpression Induces Selective Hypersensitivity to GM-CSF and Prevents Apoptosis of the GM-CSF-Dependent Acute Myelogenous Leukemia Cell Line GF-D8
7. Group A Streptococci
8. CD30-CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS FOR THERAPY OF HODGKIN LYMPHOMA (HL)
9. Innovative Therapy, Monoclonal Antibodies and Beyond
10. Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity
11. Direct comparison of in vivo fate of second and third-generation CD19-specific chimeric antigen receptor (CAR)-T cells in patients with b cell non-hodgkin lymphoma (B-NHL): Reversal of toxicity from tonic signaling
12. IM-05 * MULTISPECIFIC CAR T CELLS FOR THE TREATMENT OF HIGH GRADE GLIOMA
13. Familial High-Density Lipoprotein Deficiency (Tangier Disease): The Third Italian Case
14. Italien
15. Bortezomib sensitizes non-small cell lung cancer to mesenchymal stromal cell-delivered inducible caspase-9-mediated cytotoxicity
16. Generation and administration of autologous T cells transduced with a 3rd generation GD2 chimeric antigen receptor for patients with relapsed or refractory neuroblastoma
17. The immunogenicity of virus-derived 2A sequences in immunocompetent individuals
18. Naïve T-cell-derived CTL recognize atypical epitopes of CMVpp65 with higher avidity than CMV-seropositive donor-derived CTL - a basis for treatment of post-transplant viral infection by adoptive transfer of T-Cells from virus-naïve donors
19. Improving immune reconstitution after cord blood transplantation using ex vivo expanded virus-specific T cells: a phase I clinical study
20. Infusion of CD19-directed/multivirus specific-cytotoxic T lymphocytes after allogeneic hematopoietic stem cell transplantation for B cell malignancies
21. Robust and cost effective expansion of human regulatory T cells highly functional in a xenograft model of graft-versus-host disease
22. CLIN-IMMUNOTHERAPY/BIOLOGIC THERAPIES
23. Genetic modification of human T lymphocytes for the treatment of hematologic malignancies
24. Safety and Persistence of Infused CD19-Car-Modified Multivirus Specific CTLs in B Cell Malignancies Post Allogeneic Hematopoietic Stem Cell Transplantation
25. PRECLINICAL EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY
26. Can the well-credentialed neuroblastoma tumor antigen GD2 be exploited for T-cell-based immunotherapy of pediatric sarcomas?
27. Effect of a costimulatory endodomain on the performance of T cells expressing CD19-directed chimeric antigen receptors (CARs) in subjects with relapsed/refractory B-cell malignancies
28. Effect of a Co-Stimulatory Endodomain on the Performance of T Cells Expressing a Chimeric Antigen Receptor Directed at CD19 in Patients With Relapsed/Refractory B-Cell Malignancies
29. NaïVe T Cells From Cord Blood and CMV-Seronegative Donors Recognize Atypical Epitopes of Cmvpp65 and Can Be Used for Adoptive Immunotherapy
30. The Clinical Use of Cord Blood-Derived Virus-Specific Cytotoxic T Lymphocytes Reactive Against Cytomegalovirus (CMV), Adenovirus, and Epstein-Barr Virus (EBV)
31. Binary Control of Tumor-Specific Cytotoxic T Lymphocytes by Transgenic IL7 and IL7 Receptor Expression
32. 300 A novel immunotherapy approach for B-CLL by use of Chimeric TCR
33. Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety
34. Suicide Caspase 9 Gene For Improved Safety Of Therapies Using Mesenchymal Stromal Cells
35. Selective elimination of a chemoresistant side population of B-CLL cells by cytotoxic T lymphocytes in subjects receiving an autologous hCD40L/IL-2 tumor vaccine
36. Genetic Modification of Antigen-Specific Cytotoxic T Lymphocytes (CTLS) Restores Their Ability to Respond to Interleukin-7 (IL-7)
37. Generation Of Virus-Specific Cytotoxic T Lymphocytes (CTLS) Resistant to the Immunosuppressive Drug Tacrolimus (FK506)
38. Polyclonal Prame-Specific Cytotoxic T Lymphocytes Generated Using Protein-Spanning Pools of Overlapping Pentadecapeptides Target Chronic Myeloid Leukemia
39. Treatment of High-Risk Neuroblastoma with Adoptively Transferred T Lymphocytes Genetically Engineered to Recognize GD2
40. Rapid Generation Of Antigen-Specific T Cells for Pre-Clinical And Clinical Applications Using A Novel Mini Cell Bioreactor
41. Cytotoxic T Lymphocytes (CTL) Specific for Adenovirus and CMV Can Be Generated From Umbilical Cord Blood for Adoptive Immunotherapy
42. Monoculture-Derived Leukemia and Multivirus Specific Cytotoxic T-Lymphocytes for Immunotherapy of All in Hematopoietic Stem Cell and Umbilical Cord Blood Transplants
43. Engineering CD19-Redirected T Lymphocytes to Enhance Their Safety and Efficacy
44. PPM1A and PPM1B act as IKKβ phosphatases to terminate TNFα-induced IKKβ-NF-κB activation
45. PET imaging of T cells derived from umbilical cord blood
46. 55: T-cells Redirected Against CD70 for the Immunotherapy of Hematological Malignancies
47. 37: Cytotoxic T Lymphocytes (CTL) Specific for Multiple Viruses Can Be Generated From Umbilical Cord Blood for Adoptive Immunotherapy
48. Preferentially Expressed Antigen of Melanoma (PRAME)-Specific Cytotoxic T-Lymphocytes (CTLs) and Transgenic T Cells To Target Chronic Myelogenous Leukemia (CML).
49. Gene Transfer of IL-7R alpha (IL-7Rα) on Antigen-Specific Cytotoxic T Cells (CTLs) Restores Their Ability To Respond to IL-7 Cytokine.
50. 71: Virus-specific T cells engineered to co-express tumor-specific receptors; effects in patients with neuroblastoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.